Deals

Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from Celgene

1 source ·1 article ·2h ago

The clearance of Zenbexus is the first for a group of protein-degrading “CELMoD” medicines that could help Bristol Myers rejuvenate a key drug franchise.

Covered by 1 outlet

Biopharmadive 1

All coverage · 1 article

BioPharma Dive ·2h ago

Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from Celgene

The clearance of Zenbexus is the first for a group of protein-degrading “CELMoD” medicines that could help Bristol Myers rejuvenate a key drug franchise.

Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from Celgene

Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from Celgene →

Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from Celgene